Cantel Medical Corporation (CMN)
Cantel Medical Corporation PEG Ratio: 1.651
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CMN PEG Ratio Rankings
| Overall | 16th percentile | 1433 of 1713 |
| Sector | 18th percentile | 101 of 124 in Healthcare |
| Industry | 16th percentile | 15 of 18 in Medical Instruments & Supplies |
CMN PEG Ratio Range, Past 5 Years
| Minimum | 0.1765 | Oct 2009 |
| Maximum | 8.971 | Jul 2008 |
| Average | 1.428 |
About PEG Ratio
Click the "Learn More" link below to see how YCharts calculates the PEG Ratio.
The PEG ratio (Price/Earnings To Growth ratio) illustrates the relationship between stock price, earning per share, and the company's expected growth rate. The PEG ratio consists of the PE ratio divided by the company's growth rate. Using just the PE ratio makes high-growth companies look overvalued relative to others. By dividing the PE ratio by the earnings growth rate, the PEG ratio allows investors to accurately compare companies with different PE ratios and growth rates.
A company with a PEG ratio below 1 is considered undervalued. A company with a PEG ratio around 1 is considered fairly valued. A company with a PEG ratio greater than 1 is considered overvalued.
Learn More
You may also be interested in these CMN related companies
CMN News
Cantel Medical Appoints Seth M. Yellin As Vice President Of Corporate Development
Apr 25, 8:30AM PR Newswire
Apr 25, 8:30AM PR Newswire
Needham & Company Reiterates a 'Buy' on Cantel Medical (CMN); Raising Numbers After Another Strong Qtr
Mar 09, 7:42AM Street Insider
Mar 09, 7:42AM Street Insider
Listen to $CMN Q2 2012 earnings call - live at 11:00 AM, ondemand after - http://stks.co/2jfD
about 81 days ago by earningscast
about 81 days ago by earningscast
$SPY $CMN Cantel Medical Reports 28% Increase in Net Income - EPS of $0.27 vs. $0.22 - on 20% Sales Increase http://stks.co/2jS6 $$
about 81 days ago by WorldJazz59
about 81 days ago by WorldJazz59
@contrarian1 // buy bargains only on strong names - like when StockTwits50 go on sale $CMN $$
about 104 days ago by WorldJazz59
about 104 days ago by WorldJazz59
Biggest StockTwit50 gainers from this morning: $SWI $URI $AKRX $CMN $ULTI $PIR http://stks.co/2EoE
about 115 days ago by StockTwits
about 115 days ago by StockTwits
With 60% of the St50 stocks in red today, best performers are: $AREX $CBM $CMN $NANO
about 118 days ago by StockTwits50
about 118 days ago by StockTwits50
7 @StockTwits50 Holdings Have A NR7 Day. $AKRX $FEIC possible bull flags. $CMN rising with declining volume. http://stks.co/23H5
about 126 days ago by tradewithpete
about 126 days ago by tradewithpete
5 @StockTwits50 Holdings Have A NR7 Day. $LZB $SCSS $CMN charts posted. Other two are $SBUX $CMG http://stks.co/20Oa
about 130 days ago by tradewithpete
about 130 days ago by tradewithpete
RT @StockTwits50 St50 stocks at new 52week high: $HALO $KEX $ORLY $PNRA $NKE $FEIC $CMN
about 130 days ago by rheetta
about 130 days ago by rheetta
Cantel Medical Corp. to Present at the Needham & Company 14th Annual Growth Conference
Jan 04, 12:08PM PR Newswire
Jan 04, 12:08PM PR Newswire
Needham & Company Maintains a 'Buy' on Cantel Medical (CMN); Company’s Organic Growth Continues to Exceed Market Growth
Dec 09, 8:06AM Street Insider
Dec 09, 8:06AM Street Insider
Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its First Quarter Ended October 31, 2011
Dec 01, 12:36PM PR Newswire
Dec 01, 12:36PM PR Newswire
Cantel Medical Corp. to Present at the Stephens Inc. Fall Investment Conference
Nov 07, 2:43PM PR Newswire
Nov 07, 2:43PM PR Newswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CMN | 22.20 | -0.18 | -0.80% | 597.62M |
| CMM | 4.20 | -0.14 | -3.23% | 10.04M |
| CMLS | 2.83 | +0.02 | +0.71% | 429.06M |
| CMLP | 25.57 | +0.25 | +0.99% | 934.33M |
| CMKG | 0.90 | +0.05 | +5.88% | 7.911M |
| CMK | 8.31 | +0.04 | +0.48% | |
| CMI | 98.95 | -1.31 | -1.31% | 18.99B |
| CMG | 400.42 | -1.19 | -0.30% | 12.52B |
| CMCSA | 28.85 | -0.08 | -0.28% | 78.07B |
| CMCO | 15.16 | +0.34 | +2.29% | 293.95M |
